# FDA 483 - Robert M. Pascuzzi, M.D. - January 27, 2023

Source: https://www.globalkeysolutions.net/records/483/robert-m-pascuzzi-md/b46c4370-8e13-4f2b-a97e-0e149c5eda67

> FDA 483 for Robert M. Pascuzzi, M.D. on January 27, 2023. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Robert M. Pascuzzi, M.D.
- Inspection Date: 2023-01-27
- Product Type: drugs
- Office Name: Division of Pharmaceutical Quality Operations III
- Summary: The FDA inspected Robert M. Pascuzzi, M.D. at the Indiana University Health Neuroscience Center, a clinical investigator site in Indianapolis. The inspection revealed that the investigation was not conducted in accordance with the signed statement of investigator and investigational plan. This included deviations in subject concomitant treatment criteria and improper handling of investigational product by a blinded study team.

## Related Officers

- [Daniel B Bordt](https://www.globalkeysolutions.net/people/daniel-b-bordt/ce6549a6-511f-4e70-af4b-35d690cf69a6)
- [investigator](https://www.globalkeysolutions.net/people/dina-a-tallman/e9bf2b98-6697-4d7c-9052-84339536acfd)

Company: https://www.globalkeysolutions.net/companies/robert-m-pascuzzi-md/b04f99a0-6364-49a8-aa26-c018ea6a6dc8

Office: https://www.globalkeysolutions.net/offices/division-of-pharmaceutical-quality-operations-iii/45bc2d0d-d731-4955-aeb5-59aa0b76e4f0